Objective: Aromatase is the key enzyme for the conversion of C19 steroids into estrogen in certain human tissues. We studied to evaluate the aromatase expression in eutopic endometirum and endometriotic lesion and its relationship to clinical and laboratory parameters. Methods: The study included 78 cases of endometriotic lesion and 14 cases of eutopic endometrium and 30 cases of normal uterine endometrium obtained through laparoscopic surgery and curettage. The frozen tissue specimens were examined by immunohistochemistry using aromatase. Clinical symptoms, laboratory findings, and operative findings were analyzed and compared in according to aromatase expression. Results: We observed positive immunohistochemical expression for aromatase in endometriotic lesion from 46/78 patients (59.0%). Aromatase expression was elevated in comparison to eutopic endometrium (5/14 patients, P=0.032) and the difference was more pronounced when eutopic endometriums from patients with endometriosis were compared with those of healthy controls (2/30 patients, P<0.001). Aromatase-positive patients had more moderate-to-severe chronic pelvic pain, higher CA-125 level significantly. Also in operative findings, severe grade endometriosis, bilateral endometriomas, and associated leiomyoma and adenomyosis were more frequent in aromatase positive patients. High values of white blood cell count, erythrocyte sedimentation rate, CA 19-9 were more frequent in aromatase positive patients notwithstanding insignificant differences. Conclusion: Unopposed local biosynthesis of estrogens by increased expression of aromatase in eutopic endometrium and endometrial tissue could be involved in the development or maintenance of endometriosis and other uterine estrogen-triggered diseases. Our findings suggest increased expression of aromatase may be related with severity, activity, and chronic pelvic pain in patients with endometriosis.
infertility. Although the etiology is not well-established, several local immunological and biochemical alterations may be present. 1, 2 Abnormal levels of different cytokines and markers of inflammation were described in the serum and peritoneal fluid of women with endometriosis. These alterations are probably related to the progression of the disease, the embryotoxic activity observed in vitro, and the possible associated infertility. 3, 4 In addition, molecular anomalies such as the aberrant expression of the aromatase were described in the eutopic 5, 6 and ectopic 7 endometrium of some women with endometriosis. In general, however, aromatase expression is absent in the eutopic endometrium, and aromatase is not expressed in the endometrium of disease-free women. Aromatase is the key enzyme for the conversion of C19 steroids into estrogen in certain human tissues, such as the placenta, gonads, adipose tissue. 8 On the other hand, prostaglandin E2 (PGE2) appears to be the most potent known inducer of aromatase in endometriosis. 9, 10 This aromatase activity could give rise to a local biosynthesis of estrogen which in turn could increase PGE2
formation by up-regulation of cyclooxygenase type 2. 7, 10 Consequently, positive feedback loop for continuous local productions of estrogen and PGs is established, favoring the proliferative and inflammatory characteristics of endometriosis because of the hormone-dependent character of the disease. But, aromatase expression rate in endometriosis and its relation to clinical symptoms are reported insufficiently.
Materials and Methods
We 
Immunohistochemistry for aromatase
Immunohistochemistry for aromatase was described by Velasco et al. 14 
Tumor markers assays
The serum tumor markers CA19-9 and CA-125 were quantified by a microparticle enzyme immunoassay with the use of the AXSYM system (Abbott Diagnostics, Abbott Park, IL, USA).
Statistical analysis
All analyses were performed with the SPSS Windows Release 12.0 software package (SPSS Inc., Chicago, IL, USA). Comparisons of two groups were performed with the unpaired t-test. Differences were considered statistically significant at P<0.05.
Results
We observed positive immunohistochemical expression for aromatase in endometriotic tissues from 46 of 78 women (59.0%) ( Table 1 ).
1. Aromatase staining in uterine endometrium and endometriotic tissue from women with endometriosis Table 1 and Figure 1 were significantly higher levels of aromatase in the endometriotic lesions than in the eutopic endometrium (P<0.05) ( Table 1) .
Aromatase staining in normal endometrium
We observed stained negative for aromatase in 28 of 30 cases (93.3%) and there was weak staining in 2 of 30 cases (6.7%) in normal glandular epithelium. We were unable to detect aromatase expression in any of the stromal tissue components in the normal endometrium. There were significantly higher levels of aromatase in the eutopic endometriums than in the normal endometriums (P<0.05) ( Table 1) .
Correlation of aromatase expression with
clinical, laboratory and surgical parameters 
Discussion
It was pointed out that aberrant expression of ar-omatase in the glandular epithelium and stromal cells of endometriosis gives rise to the conversion of circulating androstenedione into estrone in this tissue, and this local estrogen production may promote the growth of endometriotic implants. 16, 17 In this study, aromatase expression was found to be significantly elevated in endometriotic glands compared with eutopic endometrium. In addition, this difference was even more pronounced when comparing uterine endometrium from endometriotic patients with that of healthy controls, supporting the hypothesis of basic differences between healthy endometrium and eutopic endometrium on a molecular level. 17 However, in this study, we found a low number of cases to relate the presence of these positive implants to the severity of symptoms. In accordance with
Heilier et al., 22 previous treatments did not affect aromatase expressions in these patients. As for tumor markers, the increase of serum CA-125 levels in relation to the severity of endometriosis has been also well-known, 23 although CA-125 value for diagnosis of the disease is limited because normal values can frequently be observed in patients with severe endometriosis. 24 The diagnostic sensibility is greater if the level of CA-125 is high. In our study, the value of 참고문헌
